論文ー2018年度ー

2018

[1] T. T. Nguyen, and S.-I. Kuroki, “Dependence of thin film transistor characteristics on low-angle grain boundaries of (100)-oriented polycrystalline silicon thin film,” Jpn. J. Appl. Phys. 58, SBBJ08-1- SBBJ08-6, 2019.

[2] T. Kurose, S.-I. Kuroki, S. Ishikawa, T. Maeda, H. Sezaki, T. Makino, T. Ohshima, M. Ostling, and C.-M. Zetterling, “Low-parasitic-capacitance self-aligned 4H-SiC nMOSFETs for harsh environ-ment electronics,” Mat. Sci. Forum, 924, pp. 971-974, 2018.

[3] J. Kajihara, S.-I. Kuroki, S. Ishikawa, T. Maeda, H. Sezaki, T. Makino, T. Ohshima, M. Ostling, and C.-M. Zetterling, “4H-SiC pMOSFETs with Al-doped S/D and NbNi silicide ohmic contacts,” Mat. Sci. Forum, 924, pp. 423-427, 2018.

[4] T. T. Nguyen, and S.-I. Kuroki, “Effect of Low Angle Grain Boundaries on Electron and Hole Mobility,” Extended Abstracts of the 2018 International Conference on Solid State Devices and Materials, Tokyo, pp. 1257-1258, 2018.

[5] J. Inoue, S.-I. Kuroki, S. Ishikawa, T. Maeda, H. Sezaki, T. Makino, T Ohshima, M. Ostling, and C.-M. Zetterling, “4H-SiC Trench pMOSFETs for High-Frequency CMOS Inverters,” 12th Euro-pean Conference on Silicon Carbide and Related Materials (ECSCRM2018), Birmingham, United Kingdom, TH-01-05, 2018.

[6] T. Ishii, S.-I. Kuroki, H. Sezaki, S. Ishikawa, T. Maeda, T. Makino, T. Ohshima, M. Ostling, and C.-M. Zetterling, “Suppression of Short-Channel Effects in 4H-SiC Trench MOSFETs,” 12th Eu-ropean Conference on Silicon Carbide and Related Materials (ECSCRM2018), Birmingham, United Kingdom, MO-P-MO7, 2018.

[7] 黒木 伸一郎, グェン ティ トゥイ, 平岩 弘之, “(100)面方位制御した超高移動度シリコン薄膜トランジスタの開発,” 応用物理, 第87巻, 第6号, p.421-4425, 2018.

[8] S.-I. Kuroki, “4H-SiC MOSFET Electronics for Harsh Environment Applications,” Proc. of the Second Int. Symp. on Devices, Circuits and Systems & Workshop (ISDCS 2019), Hiroshima, Ja-pan, 2019, (Invited).

[9] V. V. Cuong, S. Ishikawa, T. Maeda, H. Sezaki, S. Yasuno, T. Koganezawa, T. Miyazaki, and S-I. Kuroki, “High-Temperature Reliability of Ni/Nb Ohmic Contacts on 4H-SiC For Harsh Environ-ment Applications,” Thin Solid Films, 669(1), pp. 306-314, 2019.
[10] K. Kobayakawa, K. Muraoka, H. Sezaki, S. Ishikawa, T. Maeda, and S.-I. Kuroki, “Effects of CF4 surface etching on 4H-SiC MOS Capacitors,” Mat. Sci. Forum, 924, pp. 465-468, 2018.

[11] K. Muraoka, S. Ishikawa, H. Sezaki, T. Maeda, and S.-I. Kuroki, “Correlation between Field Ef-fect Mobility and Accumulation Conductance at 4H-SiC MOS Interface with Barium,” Mat. Sci. Forum, 924, pp. 477-481, 2018.

[12] M. D. Silva, T. Kawasaki, and S.-I. Kuroki, “Electrical properties of Ti-Si-C Ohmic contact on ion-implanted n-type 4H-SiC C face,” Mat. Sci. Forum, 924, pp.409-412, 2018.

[13] V. V. Cuong, S. Ishikawa, H. Sezaki, T. Maeda, S. Yasuno, T. Koganezawa, and S.-I. Kuroki, “Op-timization of Ni/Nb Ratio for High-Temperature-Reliable Ni/Nb Silicide Ohmic Contact on 4H-SiC,” 12th European Conference on Silicon Carbide and Related Materials (ECSCRM2018), Birmingham, United Kingdom, WE-P-CO3, 2018.

[14] F. Hasebe, T. Meguro, T. Makino, T. Ohshima, Y. Tanaka, and S.-I. Kuroki, “Direct Bonding of 4H-SiC and SOI Wafers for Radiation-Hardened Image Sensors,” 12th European Conference on Silicon Carbide and Related Materials (ECSCRM2018), Birmingham, United Kingdom, TU-P-RQ7, 2018.

[15] S.-I. Kuroki, K. Nagano, T. Meguro, A. Takeyama, T. Makino, T. Ohshima, and Y. Tanaka, “Ef-fects of High Gamma-Ray Radiation on 3C-SiC nMOSFETs,” 12th European Conference on Sili-con Carbide and Related Materials (ECSCRM2018), Birmingham, United Kingdom, TU-P-RQ10, 2018.

[16] T. eguro, F. asebe, A. akeyama, T. hshima, Y. anaka, and S.-I. Kuroki, “Hybrid Pixel Devices with SOI-Si photodiode and 4H-SiC MOSFETs for Radiation-Hardened Image Sensors,” 12th Europe-an Conference on Silicon Carbide and Related Materials (ECSCRM2018), Birmingham, United Kingdom, TU-P-RQ11, 2018.
[17] K. Muraoka, S. Ishikawa, H. Sezaki, T. Maeda, S.-I. Kuroki, “Characterization of Ba-introduced thin gate oxide on 4H-SiC,” 12th European Conference on Silicon Carbide and Related Materials (ECSCRM2018), Birmingham, United Kingdom, TU-P-SO6, 2018.

[18] T. Tabei, T. Sato, T. Meguro, K. Okada, S. Yamada, Y. Amemiya, S. Yokoyama, A. Nakamura, H. Murakami, S. Nishimura, K. Miyao, S. Makihira, R. Shimizu, R. Mihara, and M. Furuse, “Simpli-fied and Disposal CMOS Chip Fabrication for Biomedical Application,” Extend. Abst. Int. Conf. on Solid State Devices and Materials (SSDM2018), Tokyo, Japan, J-2-03, pp. 555-556, 2018.

[19] K. Tanimoto, Y. Amemiya, and S. Yokoyama, “Optical Waveguides with Memory Effect Using Photochromic Material for Neural Network,” Jpn. J. App. Phys. 57(4), pp. 04FH02-1-5, 2018.

[20] T. Uruma, T. Tabei, Y. Amemiya, T. Sato, S. Yamada, K. Okada, and S. Yokoyama, “New integra-tion technology of optical waveguides and photodiodes with CMOS operational amplifiers,” Ex-tend. Abst. Int. Conf. on Solid State Devices and Materials (SSDM2018), Tokyo, Japan, J-7-04, pp. 603-604, 2018.

[21] K. Tanimoto, Y. Asahara, Y. Amemiya, and S. Yokoyama, “Analysis of Optical Response Charac-teristics of Memory Waveguides with Photochromic Material,” Extend. Abst. Int. Conf. on Solid State Devices and Materials (SSDM2018), Tokyo, Japan, H-5-01, pp. 517-518, 2018.

[22] K. Tanimoto, Y. Amemiya, and S. Yokoyama, “Response Characteristics of Optical Waveguides Containing Diarylethene,” Proc. of the Second Int. Symp. on Devices, Circuits and Systems & Workshop (ISDCS 2019), Hiroshima, Japan, 2019.

[23] T. Uruma, T. Tabei, Y. Amemiya, T. Sato, S. Yamada, K. Okada, and S. Yokoyama, “Hybrid Inte-gration of Photonic Devices and CMOS Amplifiers,” Proc. of the Second Int. Symp. on Devices, Circuits and Systems & Workshop (ISDCS 2019), Hiroshima, Japan, 2019.

[24] M. Ogihara, S. Yokoyama, and Y. Amemiya, “Heterogeneous Integration of GaN Device Layer by Epitaxial Film Bonding,” Proc. of the Second Int. Symp. on Devices, Circuits and Systems & Workshop (ISDCS 2019), Hiroshima, Japan, 2019.

[25] H. Hanafusa, R. Nakashima, W. Nakano, and S. Higashi, “Extremely high-power-density atmos-pheric-pressure thermal plasma jet generated by the nitrogen-boosted effect,” Jpn. J. Appl. Phys., 57 (6S2), 06JH01-1 – 06JH01-4, 2018.

[26] S. Nagasawa, H. Hanafusa, S. Higashi, “Batteryless Operation of Single Crystalline Silicon CMOS Logic Circuits on a Flexible Substrate by Perovskite Photovoltaic Cells,” Abs. 15th Int. Thin-Film Transistor Conf. (ITC2019), Naha, Japan, pp. 86-87, 2019.

[27] S. Higashi, “Visualization of Temperature Field in Molten Silicon Formed by Thermal Plasma Jet Induced Ultra-rapid Annealing,” 2019 Int. Thin-Film Transistor Conf. (ITC2019), Naha, Japan, pp. 52-53, 2019, (Invited).

[28] S. Higashi, “Ultra-rapid Phase Transformation of Amorphous Germanium Thin-Films on Insulator Induced by Atmospheric Pressure Thermal Plasma Jet Irradiatio,” 12th International WorkShop on New Group IV Semiconductor Nanoelectronics, Sendai, Japan, 2018, (Invited).

[29] Y. Mizukawa, H. Hanafusa and S. Higashi, “Visualization of Temperature Field in Molten Silicon Formed by Atmospheric Pressure Thermal Plasma Jet Irradiation,” Proc. Int. Symp. Dry Process (DPS2018), Nagoya, Japan, pp. 39-40, 2018.

[30] H. Hanafusa, S. Higashi, and K. Shiozaki, “Capless Annealing of Mg Implanted GaN (0001) Face Using Atmospheric Pressure Thermal Plasma Jet,” Tech. Dig. International Workshop on Nitride Semiconductors (IWN2018), Kanazawa, Japan, p. 53, 2018.

[31] S. Higashi, H. Harada, and T. Nakatani, “Melting and Crystallization of Amorphous Germanium Films on Insulating Substrate By Atmospheric Pressure Micro-Thermal-Plasma-Jet,” 2018 ECS and SMEQ Joint Int. Meeting, Cancun, Mexico, #1064, 2018.

[32] Y. Mizukawa, H. Hanafusa, and S. Higashi, “Analysis of a Molten Region on Amorphous Silicon Film By High-Speed Camera and Contactless Temperature Measurement during Atmospheric Pressure Thermal Plasma Jet Annealing,” 2018 ECS and SMEQ Joint Int. Meeting, Cancun, Mexi-co, #1196, 2018, (Invited).

[33] W. Nakano, H. Hanafusa, and S. Higashi, “Ultra-High-Speed Crystallization of Amorphous Silicon Films on Flexible Glass Substrate by Thermal-PlasmaJet Irradiation Using Cylindrical Rotation Stage,” 2018 International Conference on Solid State Devices and Materials (SSDM2018), Tokyo, Japan, N-8-04, 2018.

[34] D. Todo, H. Hanafusa, and S. Higashi, “Investigation on Contact Property on Sili-con-Cap-Annealed n-type 4H-SiC,” European Conference on Silicon Carbide and Related Materi-als (ECSCRM 2018), Birmingham, UK, 2018.

[35] S. Kawasaki, H. Hanafusa, and S. Higashi, “Millisecond Annealing of 4H-SiC Wafer for Impurity Activation by Nitrogen-boosted Atmospheric Pressure Thermal Plasma Jet,” European Conference on Silicon Carbide and Related Materials (ECSCRM 2018), Birmingham, UK, 2018.

[36] S. Higashi, “Meniscus Force Mediated Transfer of Single-Crystalline Silicon Thin Films on PET Substrate and Its Application to CMOS Circuit Fabrication,” 18th International Meeting on Infor-mation Display (IMID2018), Busan, Korea, 2018, (Invited).

[37] T. Sato, S.-I. Kuroki, Y. Seino, Y. Kayaba, and T. Kikkawa, “Effect of TMCTS silylation treat-ments on crosslinking density of low-k zeolite porous silica film,” Jpn. J. Appl. Phys. 58, pp. 021003-1 – 021003-5, 2019.

[38] T. Sato, S.-I. Kuroki, Y. Kayaba and T. Kikkawa, “Low-k Mesoporous Pure Silica Zeolite Synthe-sis with the Centrifugation Process of a Zeolite Precursor,” ECS J. Solid State Sci. Technol., 7 (5), N67-N71, 2018.

[39] S. Sasada, N. Masumoto, H. Song, K. Kajitani, A. Emi, T. Kadoya, K. Arihiro, T. Kikkawa, and M. Okada, “Portable impulse-radar detector for breast cancer: a pilot study,” Journal of Medical Imaging 5(2), 025502, 2018.

[40] H. Song, H. Sato, T. Koide, K. Arihiro, M. Okada, T. Kadoya, and T. Kikkawa, “Breast Tumor Tissues Classification using the Modified Cole-Cole Parameters with Machine Learning Technique,” Proc. 12th European Concerence on Antennas and Propagation, CS33.1, London, UK, 2018.

[41] A. Azhari, and T. Kikkawa, “CMOS MIMO Switches for breast tumor screening,” International Conference on Nanomaterials and Nanotechnology, Stockholm, Sweden, 2018, (invited).

[42] Y. Masui, A. Toya, M. Sugawara, T. Maeda, M. Ono, Y. Murasaka, A. Iwata, and T. Kikkawa, “Gaussian Monocycle Pulse Generator with Calibration Circuit for Breast Cancer Detection,” Proc. BiOCAS, Cleveland, OH, USA, pp. 57-60, 2018.

[43] M. Kubo, R. Moriyama, and M. Shimada, “Facile Fabrication of HKUST-1 Nanocomposites In-corporating Fe3O4 and TiO2 Nanoparticles by a Spray-assisted Synthetic Process and Their Dye Adsorption Performances,” Microporous & Mesoporous Materials, 280, pp. 227-235, 2019.

[44] T. Tomonaga, H. Izumi, Y. Yoshiura, T. Myojo, T. Oyabu, B.-W. Lee, T. Okada, M. Kubo, M. Shimada, S. Noguchi, C. Nishida, K. Yatera, and Y. Morimoto, “Usefulness of Myeloperoxidase as a Biomarker for the Ranking of Pulmonary Toxicity of Nanomaterials,” Part. Fibre Toxicol. 15, 41, 2018.

[45] A. Nakajima, “Short Review on Fullerene-Containing Electrically Conducting Electron Beam Re-sist for Organic Biosensors with Nanostructures,” Advanced Techniques in Biology & Medicine, 6 (2), 1000257, 2018.

[46] A. Nakajima, “High Sensitive Biomolecule Detection Based on a Single-Electron Transistor,” In-ternational Biotechnology Congress-2018 (IBC-2018), Fukuoka, Japan, pp. 55-55, 2018, (Invit-ed).

[47] A. Nakajima, “Highly Sensitive Biomolecule Detection with a Single-electron Transistor,” Bio-medical Engineering-2018, Miami, FL, USA, pp. 32-32, 2018, (Invited).

[48] S. Notsu, K. Sugikawa, and A. Ikeda, “Reversible Supramolecular System of Porphyrin Exchange between Inclusion in Cyclodextrin and Intercalation in DNA by Change in pH,” Chemistry Select, 3(21), pp. 5900-5904, 2018.

[49] K. Sugikawa, Y. Inoue, K. Kozawa, and A. Ikeda, “Introduction of Fullerenes into Hydrogels via Formation of Fullerene Nanoparticles,” Chem. Nano. Mat. 4(7), pp. 682-687, 2018.

[50] R. Shimokawa, M. Ueda, K. Sugikawa, and A. Ikeda, “Control of the Incorporation and Release of Guest Molecules by Photodimerization in Liposomes,” J. Photochem. Photobiol. B, 185, pp. 235-240, 2018.

[51] K. Sugikawa, K. Matsuo, and A. Ikeda, “Suppression of Gold Nanoparticle Aggregation on Lipid Membranes Using Nanosized Liposomes to Increase Steric Hindrance,” Langmuir, 35(1), pp. 229-236, 2019.

[52] D. Antoku, K. Sugikawa, and A. Ikeda, “Photodynamic Activity of Fullerene Derivatives Wa-ter-Solubilized by Natural Product-Based Solubilizing Agents,” Chem.-Eur. J. 25(8), pp. 1854-1865, 2019.

[53] Y. Goto, K. Sugikawa, and A. Ikeda, “Enhancement in Guest Molecule Incorporation into Lipid Membranes in the Presence of Zinc-Porphyrin Anchor Molecules,” Chemistry Select, 4(1), pp. 134-137, 2019.

[54] B. Horiguchi, T. Nakaya, M. Ueda, K. Sugikawa, T. Mizuta, T. Haino, N. Kawata, and A. Ikeda, “Controllable Direction of Porphyrin Derivatives in Two Cyclodextrin Cavities,” Eur. J. Org. Chem. (18), pp. 2138-2143, 2018.

[55] D. Antoku, S. Satake, T. Mae, K. Sugikawa, H. Funabashi, A. Kuroda, and A. Ikeda, “Improve-ment of Photodynamic Activity of Lipid-Membrane-Incorporated Fullerene Derivative by Com-bination with a Photo-Antenna Molecule,” Chem.-Eur. J., 24(29), pp. 7335-7339, 2018.

[56] T. Nakaya, Y. Tsuchiya, B. Horiguchi, K. Sugikawa, K. Komaguchi, and A. Ikeda, “1H NMR De-termination of Incorporated Porphyrin Location in Lipid Membranes of Liposomes,” Bull. Chem. Soc. Jpn. 91(9), pp. 1337-1342, 2018.

[57] T. Nakaya, B. Horiguchi, K. Sugikawa, H. Funabashi, A. Kuroda, and A. Ikeda, “Stabilisation of Lipid Membrane-Incorporated Porphyrin Derivative Aqueous Solutions and Their Photodynamic Activities,” Photochem. Photobiol. Sci. 18(2), pp. 459-466, 2019.

[58] Y. Goto, M. Ueda, K. Sugikawa, K. Yasuhara, and A. Ikeda, “Light-Triggered Hydrophilic Drug Release from Liposomes through Removal of a Photolabile Protecting Group,” RSC Adv. 9(1), pp. 166-171, 2019.

[59] S. Satake, H. Shinmori, S. Kawabata, K. Sugikawa, H. Funabashi, A. Kuroda, and A. Ikeda, “High Photodynamic Activities of Water-Soluble Inclusion Complexes of 5,15-Diazaporphyrins in Cy-clodextrin,” Org. Biomol. Chem. 17(12), pp. 3141-3149, 2019.

[60] T. Ono, S. Hirata, Y. Amemiya, T. Tabei, and S. Yokoyama, “Spin Seebeck Devices Using CexY3-xFe5O12 Deposited by Metal Organic Decomposition -Influence of Composition and Long Time Annealing Effect,” Jpn. J. App. Phys. 57(4), pp. 04FN06-1-4, 2018.

[61] T. Ono, S. Hirata, Y. Amemiya, T. Tabei, and S. Yokoyama, “Anomalous Nernst Effect of Ni-Al Alloys and Application to Spin Seebeck Devices,” Jpn. J. App. Phys. 57(4), pp. 04FN05-1-5, 2018.

[62] 藤島実, “テラヘルツ通信で新しい応用を開くシリコン集積回路,” 電子情報通信学会誌, 101(6), pp. 554-560, 2018.

[63] M. Fujishima, “Key Technologies for THz Wireless Link by Silicon CMOS Integrated Circuits,” Photonics, 5(4), pp. 1-17, 2018.

[64] 藤島実, “CMOS集積回路を用いたテラヘルツ広帯域通信とその応用,” 電子情報通信学会 通信ソサイエティマガジン, 12(3), pp. 190-196, 2018.

[65] M. Fujishima, “Emerging applications with terahertz communication,” International Journal of Terahertz Science and Technology (TST), 11(4), pp. 124-130, 2018, (Invited).

[66] S. Hara, K. Katayama, K. Takano, R. Dong, I. Watanabe, N Sekine, A. Kasamatsu, T. Yoshida, S. Amakawa, and M. Fujishima, “32-Gbit/s CMOS receivers in 300GHz band,” IEICE Trans. Electron. E101-C(7), pp. 464-471, 2018.

[67] 藤島実, 天川修平, 高塚弘隆, “(招待論文) 低電圧電源ミリ波CMOS回路,” 電子情報通信学会論文誌 C, J101-C(9), pp. 362-369, 2018.

[68] S. Lee, K. Takano, R. Dong, S. Amakawa, T. Yoshida, and M. Fujishima, “A 300-μW K-Band Os-cillator with High-Q Open Stub Capacitor in 55-nm CMOS DDC,” TH2, The 2018 IEEE Interna-tional Symposium on Radio-Frequency Integration Technology (RFIT2018), Melborne, 2018.

[69] R. Dong, K. Katayama, K. Takano, S. Lee, T. Yoshida, S. Amakawa, and M. Fujishima, “A 79-85 GHz CMOS Amplifier with 0.35 V Supply Voltage,” 2018 13th European Microwave Integrated Circuits Conference (EuMIC), Madrid, 2018.

[70] K. Takano, R. Dong, S. Lee, S. Amakawa, T. Yoshida, and M. Fujishima, “A 239-315 GHz CMOS Frequency Doubler Designed by Using a Small-Signal Nonlinear Model,” 2018 13th European Microwave Integrated Circuits Conference (EuMIC), Madrid, 2018.

[71] S. Hara, K. Takano, K. Katayama, R. Dong, K. Mizuno, K. Takahashi, I. Watanabe, N. Sekine, A. Kasamatsu, T. Yoshida, S. Amakawa, and M. Fujishima, “300-GHz CMOS Receiver Module with WR-3.4 Waveguide Interface,” 2018 48th European Microwave Conference (EuMC), Madrid, 2018.

[72] S. Lee, K. Takano, R. Dong, S. Amakawa, T. Yoshida, and M. Fujishima, “A 37-GHz-Input Di-vide-by-36 Injection-Locked Frequency Divider with 1.6-GHz Lock Range,” IEEE Asian Sol-id-State Circuits Conference (A-SSCC 2018), Tainan, 2018.

[73] S. Lee, R. Dong, T. Yoshida, S. Amakawa, S. Hara, A. Kasamatsu, J. Sato, and M. Fujishima, “An 80Gb/s 300GHz-Band Single-Chip CMOS Transceiver,” 2019 International Solid-State Circuits Conference (ISSCC 2019), San Francisco, 2019.

[74] T. Vu, K. Takano, and M. Fujishima, “Low-power D-band CMOS amplifier for ultrahigh-speed wireless communications,” International Journal of Electrical and Computer Engineering, 8(2), 2018.

[75] T. Vu, K. Takano, and M. Fujishima, “300-GHz Balanced Varactor Doubler in Silicon CMOS for Ultrahigh-Speed Wireless Communications,” IEEE Microwave Theory and Techniques Society, 28(4), pp. 341-343, 2018.

[76] K. Kageyama, T. Koide, and T. Kumaki, “Parallel Processing of Morphological Pattern Spectrum for a Massive-Parallel Memory-Embedded SIMD Matrix Processor MX-1”, IEEJ Transactions on Electronics, Information and Systems, 139(3), pp.237-246, 2019.

[77] K. Kageyama, T. Koide, and T. Kumaki, “Structuring Element-counting Approach for Morpho-logical Pattern Spectrum-based Image Manipulation Detection”, The 2nd International Symposium on Devices, Circuits and Systems (ISDCS2019), Hiroshima, Japan, 2019.

[78] K. Inoue, N. Kobori, A. Hirota, T. Koide and T. Okamoto, “An IoT-gateway with the infor-mation-centric communication”, The 2nd International Symposium on Devices, Circuits and Sys-tems (ISDCS2019), Hiroshima, Japan, 2019.

[79] T. Okamoto, T. Koide, T. Tamaki, B.Raytchev, K.Kaneda, S. Yoshida, H.Mieno, and S. Tanaka, “Feature Extraction of Colorectal Endoscopic Images for Computer-Aided Diagnosis with CNNT”, The 2nd International Symposium on Devices, Circuits and Systems (ISDCS2019), Hiroshima, Japan, 2019.

[80] T. Okamoto, T. Koide, T. Tamaki, B. Raytchev, K. Kaneda, S. Yoshida, H. Mieno, S. Tanaka, H. Toishi, T. Sugawara, M. Tsuji, M. Odagawa, and N. Tamba, “Implementation of Computer-Aided Diagnosis System on Customizable DSP Core for Colorectal Endoscopic Images with CNN Features and SVM,” Proceedings of the IEEE Region 10 Conference 2018 (TENCON2018), pp. 1669-1672, 2018.

[81] 岡本拓巳, 小出哲士, 玉木徹, Bisser Raytchev, 金田和文, 吉田成人, 三重野寛, 田中信治, 菅原崇之, 戸石浩司, 辻雅之, 小田川真之, 丹場展雄, “大腸がん診断支援のためのカスタマイザブルDSPによる内視鏡動画リアルタイムCNN特徴抽出とSVM分類,” 情報処理学会DAシンポジウム2018,pp. 39‐45,2018.

[82] T. Okamoto, T. Koide, T. Tamaki, B. Raytchev, K. Kaneda, S. Yoshida, H. Mieno, S. Tanaka, “In-vestigation of Real-Time Computer-Aided Diagnosis system using CNN feature and SVM identifier with Colorectal Endoscopic Images,” Proceedings of the 21th Workshop on Synthesis And System Integration of Mixed Information technologies (SASIMI 2018), pp.71 – 76, 2018.

[83] T. Kasama, T. Koide, W. P. Bula, Y. Yaji, Y. Endo, and R. Miyake, “LowCost and Robust Field-Deployable Environmental Sensor for Smart Agriculture,” The 2nd International Symposium on Devices, Circuits and Systems (ISDCS2019), March 7, 2019, Hiroshima, Japan, 2019.

[84] H. Murakami, Y. Tanaka, J.-I. Yamashita, R. Takeshita, T. Okamoto, Y. Sakane, and T. Koide, “Development of In-situ Monitoring System for Crop Growth Observation,” The 2nd International Symposium on Devices, Circuits and Systems (ISDCS2019), March 7, 2019, Hiroshima, Japan, 2019.

[85] P. Gao, T. Kasama, M. Godonoga, Y. Endo, T. Koide, A. Ogawa, and R. Miyake, “Nano-litter micro sampling device for extracting sample from plants,” Proc. of the 22nd International Conference on Miniaturized Systems for Chemistry and Life Sciences (microTAS 2018), Kaohsiung, Taiwan, 2018.

[86] R. Miyake, T. Kasama, W. P. Bula, M. Godonoga, Y. Endo, T. Okamoto, T. Koide, C. Sone, M. Komine, Y. Ishimito, Y. Yaji, Y. Kaneta, and A. Ogawa, “Plant vascular system as a micro-fluidic circuit,” Proc. of International Conference on Micro Reaction Technology – IMRET 2018, Karlsruhe, Germany, 2018.

[87] T. Okamoto, Y. Sakane, T. Koide, A. Ogawa, M. Komine, C. Sone, Y. Kaneta, Y. Yaji, K. Toyofuku, T. Kamata, K. Kimura, Y. Ishikawa, T. Kasama, W.-P. Bula, Y. Endo, and R. Miyake, “An Image Analysis Method for Lettuce Leaf and Root Growth Analysis in Hydroponic Culture,” Proceedings of the IEEE Region 10 Conference 2018 (TENCON2018), pp. 467-470, 2018.

[88] P. Gao, T. Kasama, M. Godonoga, Y. Endo, T. Koide, A. Ogawa, and R. Miyake, “A micro sampling device for extracting Nano-litter sample from plant,” The 10th International Symposium on Mi-crochemistry and Microsystems, Busan, Korea, 2018.

[89] Y. Amemiya, A. K. Sana, Y. Nakashima, J. Maeda, and S. Yokoyama, “Silicon Photonic Biosen-sors with MEMS Flow Control,” Jpn. J. App. Phys. 57(4), pp. 04FC10-1-5, 2018.

[90] J. Maeda, R. Funamoto, Y. Amemiya, and S. Yokoyama, “Effect of Anti-Reflective Coating for Si Optical Resonator Biosensors,” Proc. of the Second Int. Symp. on Devices, Circuits and Systems & Workshop (ISDCS 2019), Hiroshima, Japan, 2019.

[91] M. Iwasaka, and H. Asada, “Floating photonic crystals utilizing magnetically aligned biogenic gua-nine platelets,” Scientific Reports, 8, 16940, 2018.

[92] T. Chikashige, and M. Iwasaka, “Magnetically-assembled micro/mesopixels exhibiting light inten-sity enhancement in the (012) planes of fish guanine crystals,” AIP Advances 8, 056704, 2018.
[93] A. Mootha, Y. Takanezawa, and M. Iwasaka, “Quenching of light flickering in synthetic guanine crystals in aqueous solutions under strong static magnetic fields,” AIP Advances 8, 056715, 2018.

[94] M. Iwasaka, N. Hirota, and Y. Oba, “Magnetically tunable oil droplet lens of deep-sea shrimp,” AIP Advances 8, 056436, 2018.

[95] T. Sogame, E. Muneyama, M. Inoue, T. Kimura, H. Asada, M. Iwasaka, K. Kishimoto, and T. Ko-yanagi, “Micro Optical-Interference-Plate Featuring Highly Efficient Diamagnetic Rotation of Bi-ogenic Crystals,” IEEE Transactions on Magnetics, pp. 1-4, 2018.

[96] T. Sogame, K. Deguchi, T. Kimura, E. Muneyama, M. Inoue, H. Asada, M. Iwasaka, K. Kishimoto, and T. Koyanagi, “Fabrication of Biogenic Guanine Crystal/Ferromagnetic Film Hybrid Plate for Micro-Optical Micro-Electromechanical Systems,” IEEE Transactions on Magnetics, pp. 1-4, 2018.

[97] A. Mootha, K. Suzuki, H. Asada, M. Iwasaka, “Guanine Vesicle Hybrid Particles for Bio-Reflector-Based Bio-Imaging,” IEEE Transactions on Magnetics, pp. 1-4, 2018.

[98] T. Sogame, K. Deguchi, M. Inoue, T. Kimura, E. Muneyama, K. Kishimoto, T. Koyanagi, H. Asa-da, and M. Iwasaka, “Fabrication of biogenic guanine crystal/ferromagnetic film hybrid plate for micro-optical MEMS,” 2018 IEEE International Magnetic Conference (INTERMAG), 2018.

[99] H. Kashiwagi, H. Asada, and M. Iwasaka, “Optical Behavior of Guanine Microcrystals from Aquatic Species upon Exposure to a Magnetic Field,” 2018 IEEE International Magnetic Confer-ence (INTERMAG), 2018.

[100] H. Kashiwagi, M. Iwasaka, H. Asada, T. Koyanagi, and K. Kishimoto, “Magnetically Controlled Light Manipulating Properties of Biogenic and Synthetic Guanine Crystals,” 2018 IEEE Interna-tional Magnetic Conference (INTERMAG), 2018.

[101] I. Otani, S. Oka, S. Tanaka, S. Iio, A. Tsuboi, S. Kunihara, Y. Hiyama, and K. Chayama, “Diag-nostic Yield of Colon Capsule Endoscopy in Detection of Superficial Colorectal Lesions,” Diges-tion. 27, pp. 1-8, 2019.

[102] Y. Ishii, M. Serikawa, T. Sasaki, Y. Fujimoto, A. Yamaguchi, T. Ogawa, B. Noma, A. Okazaki, M. Yukutake, T. Ishigaki, and K. Chayama, “Impact of sclerosing dacryoadenitis/sialadenitis on re-lapse during steroid therapy in patients with type 1 autoimmune pancreatitis,” Scand J Gastroen-terol. 27, pp.1-6, 2019.

[103] K. Nakamura, Y. Urabe, S. Oka, M. Ito, T. Kotachi, Y. Ninomiya, T. Boda, T. Hiyama, M. Emi, Y. Hamai, N. Shiroma, S. Tanaka, and K. Chayama, “A case of primary malignant melanoma of the esophagus with a widely expanded surface area,” Clin J Gastroenterol. pp. 424-428, 2019.

[104] A. Hiramatsu, H. Aikata, S. Uchikawa, K. Ohya, K. Kodama, Y. Nishida, K. Daijo, M. Osawa, Y. Teraoka, F. Honda, Y. Inagaki, K. Morio, R. Morio, H. Fujino, T. Nakahara, E. Murakami, M. Yamauchi, T. Kawaoka, D. Miki, M. Tsuge, M. Imamura, J. Tanaka, and K. Chayama, “Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrho-sis,” Hepatol Commun. 3, pp. 348-355. 2019.

[105] M. Amioka, Y. Nakano, H. Ochi, Y. Onohara, A. Sairaku, T. Tokuyama, C. Motoda, H. Matsumu-ra, S. Tomomori, N. Hironobe, Y. Okubo, S. Okamura, K. Chayama, and Y. Kihara, “Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recur-rence after catheter ablation in patients with paroxysmal atrial fibrillation,” PLoS One, 14, e0213208, 2019.

[106] K. Tsushima, M. Tsuge, N. Hiraga, T. Uchida, E. Murakami, G. N. Makokha, M. Kurihara, M. Nomura, Y. Hiyama, H. Fujino, A. Ono, T. Nakahara, M. Yamauchi, H. Abe Chayama, T. Kawa-oka, D. Miki, M. Imamura, H. Aikata, C. N. Hayes, and K. Chayama, “Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric mice,” J Gas-troenterol. 54, pp. 650-659, 2019.

[107] D. Hirano, Y. Urabe, S. Tanaka, K. Nakamura, Y. Ninomiya, R. Yuge, R. Hayashi, S. Oka, Y. Kit-adai, F. Shimamoto, K. Arihiro, and K. Chayama, “Early-stage serrated adenocarcinomas are di-vided into several molecularly distinct subtypes,” PLoS One, 14, e0211477, 2019.

[108] M. Namba, T. Kawaoka, H. Aikata, K. Kodama, S. Uchikawa, K. Ohya, K. Morio, H. Fujino, T. Nakahara, E. Murakami, M. Yamauchi, M. Tsuge, A. Hiramatsu, M. Imamura, Y. Baba, K. Awai, and K. Chayama, “Percutaneous transvenous shunt occlusion for portosystemic encephalopathy due to lenvatinib administration to a patient with hepatocellular carcinoma and portosystemic shunt,” Clin J Gastroenterol. 12, 341, 2019.

[109] H. Tanaka, S. Oka, S. Tanaka, K. Inagaki, Y. Okamoto, K. Matsumoto, K. Boda, K. Yamashita, K. Sumimoto, Y. Ninomiya, N. Hayashi, and K. Chayama, “The utility of a novel colonoscope with retroflexion for colorectal endoscopic submucosal dissection,” Endosc Int Open. 7, pp. E130-E137. 2019.

[110] A. Tsuboi, S. Oka, S. Tanaka, S. Iio, I. Otani, S. Kunihara, and K. Chayama, “The Clinical Use-fulness of the PillCam Progress Indicator for Route Selection in Double Balloon Endoscopy,” In-tern Med. 58, 1375, 2019.

[111] K. Hata, M. Ito, T. Boda, T. Kotachi, M. Kiso, K. Masuda, M. Kurihara, K. Kuroki, N. Yorita, N. Nagasaki, M. Abduwali, S. Tanaka, and K. Chayama, “Gastric Cancer with Submucosal Invasion after Successful Helicobacter pylori Eradication: A Propensity Score-Matched Analysis of Patients with Annual Patient Endoscopic Survey,” Digestion. 99, pp. 59-65, 2019.

[112] S. Uchikawa, T. Kawaoka, H. Aikata, K. Kodama, Y. Inagaki, M. Hatooka, K. Morio, T. Nakahara, E. Murakami, A. Hiramatsu, M. Tsuge, M. Imamura, Y. Kawakami, and K. Chayama, “Early ex-perience of seven hepatocellular carcinoma cases treated with regorafenib,” Clin Case Rep. 6, pp. 2217-2223, 2018.

[113] Y. Nagaoki, M. Imamura, Y. Nishida, K. Daijo, Y. Teraoka, F. Honda, Y. Nakamura, K. Morio, H. Fujino, T. Nakahara, T. Kawaoka, M. Tsuge, A. Hiramatsu, Y. Kawakami, D. Miki, Y. Hiyama, H. Ochi, K. Chayama, and H. Aikata, “The impact of interferon-free direct-acting antivirals on clini-cal outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapy,” J Med Virol. 91, pp. 650-658, 2019.

[114] M. Osawa, M. Imamura, Y. Teraoka, T. Uchida, K. Morio, H. Fujino, T. Nakahara, A. Ono, E. Murakami, T. Kawaoka, D. Miki, M. Tsuge, A. Hiramatsu, H. Aikata, C.N. Hayes, and K. Chayama, “Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures,” J Gastroenterol. 54, pp. 291-296, 2019.

[115] R. Hayashi, Y. Ueno, S. Tanaka, M. Wakai, J. Kumada, A. Fujita, M. Nomura, S. Oka, M. Ito, and K. Chayama, “Rectal Lymphoid Follicle Aphthous Lesions Frequently Progress to Ulcerative Coli-tis with Proximal Extension,” Intern Med. 58, pp. 625-631, 2019.

[116] H. Tanaka, S. Oka, S. Tanaka, K. Matsumoto, K. Boda, K. Yamashita, D. Hirano, K. Sumimoto, Y. Tamaru, Y. Ninomiya, N. Hayashi, and K. Chayama, “Dual Red Imaging Maintains Clear Visibility During Colorectal Endoscopic Submucosal Dissection,” Dig Dis Sci. 64, pp. 224-231, 2019.

[117] S. Tomomori, Y. Nakano, H. Ochi, Y. Onohara, A. Sairaku, T. Tokuyama, C. Motoda, H. Matsu-mura, M. Amioka, N. Hironobe, Y. Okubo, S. Okamura, H. Kawazoe, Y. Nishiyama, H. Tahara, K. Chayama, and Y. Kihara, “Chromosome 4q25 Variant rs6817105 Bring Sinus Node Dysfunction and Left Atrial Enlargement,” Sci Rep. 8, 14565, 2018.

[118] S. Tomomori, Y. Nakano, H. Ochi, Y. Onohara, A. Sairaku, T. Tokuyama, C. Motoda, H. Matsu-mura, M. Amioka, N. Hironobe, Y. Ookubo, S. Okamura, H. Kawazoe, K. Chayama, and Y. Ki-hara, “Maintenance of low inflammation level by the ZFHX3 SNP rs2106261 minor allele con-tributes to reduced atrial fibrillation recurrence after pulmonary vein isolation,” PLoS One, 13, e0203281, 2018.

[119] Y. Urabe, K. Kagemoto, K. Nakamura, T. Mizumoto, Y. Sanomura, S. Oka, H. Ochi, S. Tanaka, and K. Chayama, “Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma,” Esophagus. 16, pp. 141-146, 2019.

[120] S. Kunihara, S. Oka, S. Tanaka, A. Tsuboi, I. Otani, and K. Chayama, “Management of occult ob-scure gastrointestinal bleeding patients based on long-term outcomes,” Therap Adv Gastroenterol. 11, 2018.

[121] T. Kawaoka, H. Aikata, T. Kobayashi, S. Uchikawa, K. Ohya, K. Kodama, Y. Nishida, K. Daijo, M. Osawa, Y. Teraoka, Y. Inagaki, F. Honda, M. Hatooka, K. Morio, R. Morio, H. Fujino, T. Nakaha-ra, E. Murakami, M. Tsuge, A. Hiramatsu, M. Imamura, Y. Kawakami, Y. Baba, K. Awai, and K. Chayama, “Comparison of hepatic arterial infusion chemotherapy between 5-fluorouracil-based continuous infusion chemotherapy and low-dose cisplatin monotherapy for advanced hepatocel-lular carcinoma,” Hepatol Res. 48, pp. 1118-1130, 2018.

[122] M. Nomura, M. Tsuge, T. Uchida, N. Hiraga, M. Kurihara, K. Tsushima, H. Fujino, T. Nakahara, E. Murakami, H. Abe-Chayama, T. Kawaoka, D. Miki, A. Hiramatsu, M. Imamura, Y. Kawakami, H. Aikata, H. Ochi, Y. Zhang, G.N. Makokha, C.N. Hayes, S. Tanaka, and K. Chayama, “CTL-associated and NK cell-associated immune responses induce different HBV DNA reduction patterns in chronic hepatitis B patients,” J Viral Hepat. 25, pp. 1555-1564, 2018.

[123] K. Yamashita, S. Oka, S. Tanaka, K. Boda, D. Hirano, K. Sumimoto, T. Mizumoto, Y. Ninomiya, Y. Tamaru, K. Shigita, N. Hayashi, Y. Sanomura, and K. Chayama, “Use of anticoagulants in-creases risk of bleeding after colorectal endoscopic submucosal dissection,” Endosc Int Open. 6, pp. E857-E864, 2018.

[124] Y. Teraoka, T. Uchida, M. Imamura, N. Hiraga, M. Osawa, H. Kan, Y. Saito, M. Tsuge, H. Abe-Chayama, C.N. Hayes, G.N. Makokha, H. Aikata, D. Miki, H. Ochi, Y. Ishida, C. Tateno, and K. Chayama, “Limitations of daclatasvir/asunaprevir plus beclabuvir treatment in cases of NS5A inhibitor treatment failure,” J Gen Virol. 99, pp. 1058-1065, 2018.

[125] K. Boda, S. Oka, S. Tanaka, H. Tanaka, K. Matsumoto, K. Yamashita, K. Sumimoto, D. Hirano, Y. Tamaru, Y. Ninomiya, N. Hayashi, and K. Chayama, “Short-term outcomes of endoscopic sub-mucosal dissection for superficial cecal tumors: a comparison between extension and nonexten-sion into the appendiceal orifice,” Therap Adv Gastroenterol. 11, 2018.

[126] N. R. Nakano, M. Ohira, T. Kobayashi, K. Ide, H. Tahara, S. Kuroda, S. Shimizu, T. Kimura, Y. Nagata, H. Aikata, K. Chayama, and H. Ohdan, “Hepatectomy versus stereotactic body radiother-apy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institu-tion,” Surgery. 164, pp. 219-226, 2018.

[127] S. Uchikawa, T. Kawaoka, H. Aikata, K. Kodama, Y. Nishida, Y. Inagaki, M. Hatooka, K. Morio, T. Nakahara, E. Murakami, A. Hiramatsu, M. Tsuge, M. Imamura, Y. Kawakami, and K. Chayama, “Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and can-didates for regorafenib treatment in real-world practice,” Hepatol Res. 48, pp. 814-820, 2018.

[128] S. Kunihara, S. Oka, S. Tanaka, I. Otani, A. Igawa, Y. Nagaoki, H. Aikata, and K. Chayama, “Pre-dictive Factors of Portal Hypertensive Enteropathy Exacerbation in Patients with Liver Cirrhosis: A Capsule Endoscopy Study,” Digestion. 98, pp. 33-40, 2018.

[129] Y. Teraoka, T. Uchida, M. Imamura, M. Osawa, M. Tsuge, H. Abe-Chayama, C.N. Hayes, G.N. Makokha, H. Aikata, D. Miki, H. Ochi, Y. Ishida, C. Tateno, and K. Chayama, “Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice,” Biochem Biophys Res Commun. 500, pp. 152-157, 2018.

[130] T. Mizumoto, T. Hiyama, S. Oka, N. Yorita, K. Kuroki, M. Kurihara, Y. Yoshifuku, Y. Sanomura, Y. Urabe, Y. Murakami, K. Arihiro, S. Tanaka, and K. Chayama, “Curative Criteria After Endo-scopic Resection for Superficial Esophageal Squamous Cell Carcinomas,” Dig Dis Sci. 63, pp. 1605-1612, 2018.

[131] T. Kaishima, T. Akita, M. Ohisa, K. Sakamune, A. Kurisu, A. Sugiyama, H. Aikata, K. Chayama, and J. Tanaka, “Cost-effectiveness analyses of anti-hepatitis C virus treatments using quality of life scoring among patients with chronic liver disease in Hiroshima prefecture, Japan,” Hepatol Res. 48, pp. 509-520, 2018.

[132] T. Mizumoto, T. Hiyama, S. Oka, N. Yorita, K. Kuroki, M. Kurihara, Y. Yoshifuku, Y. Sanomura, Y. Urabe, K. Arihiro, S. Tanaka, and K. Chayama, D”iagnosis of superficial esophageal squamous cell carcinoma invasion depth before endoscopic submucosal dissection,” Dis Esophagus. 31, 2018.

[133] M. Yamauchi, Y. Urabe, A. Ono, D. Miki, H. Ochi, and K. Chayama, “Serial profiling of circulat-ing tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer pa-tients,” Int J Cancer. 142, pp. 1418-1426, 2018.

[134] I. Otani, S. Oka, S. Tanaka, A. Tsuboi, S. Kunihara, Y. Nagaoki, H. Aikata, and K. Chayama, “Clinical significance of small-bowel villous edema in patients with liver cirrhosis: A capsule en-doscopy study,” J Gastroenterol Hepatol. 33, pp. 825-830, 2018.

[135] K. Yamashita, S. Oka, S. Tanaka, S. Nagata, T. Kuwai, A. Furudoi, T. Tamura, M. Kunihiro, H. Okanobu, K. Nakadoi, H. Kanao, M. Higashiyama, K. Arihiro, K. Kuraoka, F. Shimamoto, and K. Chayama, “Long-term prognosis after treatment for T1 carcinoma of laterally spreading tumors: a multicenter retrospective study,” Int J Colorectal Dis. 34, 481, 2019.

[136] M. Tsuge, N. Hiraga, Y. Zhang, M. Yamashita, O. Sato, N. Oka, K. Shiraishi, Y. Izaki, G.N. Ma-kokha, T. Uchida, M. Kurihara, M. Nomura, K. Tsushima, T. Nakahara, E. Murakami, H. Abe-Chayama, T. Kawaoka, D. Miki, M. Imamura, Y. Kawakami, H. Aikata, H. Ochi, C.N. Hayes, T. Fujita, and K. Chayama, “Endoplasmic reticulum-mediated induction of interleukin-8 occurs by hepatitis B virus infection and contributes to suppression of interferon responsiveness in hu-man hepatocytes,” Virology. 525, pp. 48-61, 2018.

[137] K. Morio, M. Imamura, Y. Kawakami, Y. Nakamura, M. Hatooka, R. Morio, H. Fujino, T. Naka-hara, E. Murakami, T. Kawaoka, M. Tsuge, A. Hiramatsu, H. Aikata, C.N. Hayes, D. Miki, H. Ochi, Y. Katamura, K. Arataki, T. Moriya, H. Ito, K. Tsuji, H. Kohno, K. Waki, T. Tamura, T. Nakamura, and K. Chayama, “Advanced liver fibrosis effects on the response to sofosbuvir-based antiviral therapies for chronic hepatitis C,” J Med Virol. 90, pp. 834-1840, 2018.

[138] M. Hatooka, T. Kawaoka, H. Aikata, Y. Inagaki, K. Morio, T. Nakahara, E. Murakami, M. Tsuge, A. Hiramatsu, M. Imamura, Y. Kawakami, K. Awai, K. Masaki, K. Waki, H. Kohno, T. Moriya, Y. Nagaoki, T. Tamura, H. Amano, Y. Katamura, and K. Chayama, “Hepatic arterial infusion chemo-therapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial,” BMC Cancer. 18, 633, 2018.

[139] H. Itsuki, M. Serikawa, T. Sasaki, Y. Ishii, K. Tsushima, Y. Furukawa, Y. Murakami, K. Arihiro, and K. Chayama, “Indication and Usefulness of Bile Juice Cytology for Diagnosis of Gallbladder Cancer,” Gastroenterol Res Pract. 2018, 5410349, 2018.

[140] T. Kotachi, M. Ito, T. Boda, M. Kiso, K. Masuda, K. Hata, T. Kawamura, Y. Sanomura, M. Yoshi-hara, S. Tanaka, and K. Chayama, “Clinical Significance of Reddish Depressed Lesions Observed in the Gastric Mucosa after Helicobacter pylori Eradication,” Digestion. 98, pp. 48-55, 2018.

[141] K. Kodama, T. Kawaoka, H. Aikata, S. Uchikawa, Y. Inagaki, M. Hatooka, K. Morio, T. Nakahara, E. Murakami, M. Tsuge, A. Hiramatsu, M. Imamura, Y. Kawakami, K. Masaki, Y. Honda, N. Mori, S. Takaki, K. Tsuji, H. Kohno, T. Moriya, M. Nonaka, H. Hyogo, Y. Aisaka, and K. Chayama, “Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for ad-vanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status,” J Gastroenterol Hepatol. 33, pp. 1780-1786, 2018.

[142] F. Honda, A. Hiramatsu, H. Hyogo, H. Aikata, K. Daijo, Y. Teraoka, Y. Inagaki, K. Morio, T. Ko-bayashi, T. Nakahara, Y. Nagaoki, T. Kawaoka, M. Yoneda, M. Tsuge, M. Imamura, Y. Kawakami, H. Ochi, and K. Chayama, “Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring,” PLoS One, 13, e0195028, 2018.

[143] R. Yuge, Y. Kitadai, H. Takigawa, T. Naito, N. Oue, W. Yasui, S. Tanaka, and K. Chayama, “Si-lencing of Discoidin Domain Receptor-1 (DDR1) Concurrently Inhibits Multiple Steps of Metasta-sis Cascade in Gastric Cancer,” Transl Oncol. 11, pp. 575-584, 2018.

[144] A. Tari, Y. Kitadai, R. Mouri, H. Takigawa, H. Asaoku, K. Mihara, K. Takata, M. Fujihara, T. Yoshino, T. Koga, S. Fujimori, S. Tanaka, and K. Chayama, “Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma,” J Gastroenterol Hepatol. 33, pp. 1461-1468, 2018.

[145] Y. Kawakami, H. Ochi, C. N. Hayes, M. Imamura, M. Tsuge, T. Nakahara, Y. Katamura, H. Kohno, H. Kohno, K. Tsuji, S. Takaki, N. Mori, Y. Honda, K. Arataki, S. Takahashi, S. Kira, T. Tamura, K. Masuda, T. Nakamura, M. Kikkawa, and K. Chayama, “Efficacy and safety of ledipas-vir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study,” J Gastroenterol. 53, pp. 548-556, 2018.

[146] M. Kajikawa, T. Maruhashi, S. Kishimoto, S. Matsui, H. Hashimoto, Y. Takaeko, F.M. Yusoff, Y. Kihara, K. Chayama, C. Goto, K. Noma, A. Nakashima, H. Tomiyama, B. Takase, T. Kohro, T. Suzuki, T. Ishizu, S. Ueda, T. Yamazaki, T. Furumoto, K. Kario, T. Inoue, S. Koba, K. Watanabe, Y. Takemoto, T. Hano, M. Sata, Y. Ishibashi, K. Node, K. Maemura, Y. Ohya, T. Furukawa, H. Ito, H. Ikeda, A. Yamashina, and Y. Higashi, “Target of Triglycerides as Residual Risk for Cardiovas-cular Events in Patients With Coronary Artery Disease – Post Hoc Analysis of the FMD-J Study A,” Circ J. 83, 1064, 2019.

[147] K. Takaguchi, H. Toyoda, A. Tsutsui, Y. Suzuki, M. Nakamuta, M. Imamura, T. Senoh, T. Nagano, T. Tada, Y. Tachi, A. Hiraoka, K. Michitaka, H. Shibata, K. Joko, H. Okubo, K. Tsuji, S. Takaki, T. Watanabe, C. Ogawa, K. Chayama, T. Kumada, M. Kudo, and H. Kumada, “Real-world virologi-cal efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan,” J Gastroenterol. 54, pp. 724-751, 2019.

[148] T. Maruhashi, Y. Kinoshita, M. Kajikawa, S. Kishimoto, S. Matsui, H. Hashimoto, Y. Takaeko, Y. Aibara, F.M. Yusoff, T. Hidaka, K. Chayama, K. Noma, A. Nakashima, C. Goto, M. Takahashi, Y. Kihara, and Y. Higashi, “Relationship between home blood pressure and vascular function in pa-tients receiving antihypertensive drug treatment,” Hypertens Res. 42, pp. 1175-1185, 2019.

[149] F. Takeuchi, S. Ikeda, Y. Tsukamoto, Y. Iwasawa, C. Qihao, Y. Otakaki, O. Ryota, W.L. Yao, R. Narita, H. Makoto, K. Watashi, T. Wakita, K. Takeuchi, K. Chayama, A. Kogure, H. Kato, and T. Fujita, “Screening for inhibitor of episomal DNA identified dicumarol as a hepatitis B virus inhib-itor,” PLoS One, 14, e0212233, 2019.

[150] K. Kodama, T. Kawaguchi, H. Hyogo, T. Nakajima, M. Ono, M. Seike, H. Takahashi, Y. Nozaki, M. Kawanaka, S. Tanaka, K. Imajo, Y. Sumida, Y. Kamada, H. Fujii, Y. Seko, T. Takehara, Y. Itoh, A. Nakajima, N. Masaki, T. Torimura, T. Saibara, Y. Karino, K. Chayama, and K. Tokushige, “Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis,” J Gastroenterol Hepatol. 34, pp. 1626-1632, 2019.

[151] H. Fujii, K. Imajo, M. Yoneda, T. Nakahara, H. Hyogo, H. Takahashi, T. Hara, S. Tanaka, Y. Su-mida, Y. Eguchi, K. Chayama, A. Nakajima, N. Nishimoto, and N. Kawada, “An independent pre-dictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease,” J Gastroenterol Hepatol. 34, pp. 1390-1395, 2019.

[152] R. Tateishi, K. Uchino, N. Fujiwara, T. Takehara, T. Okanoue, M. Seike, H. Yoshiji, H. Yatsuhashi, M. Shimizu, T. Torimura, M. Moriyama, I. Sakaida, H. Okada, T. Chiba, M. Chuma, K. Nakao, H. Isomoto, Y. Sasaki, S. Kaneko, T. Masaki, K. Chayama, and K. Koike, “A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update,” J Gastroenterol. 54, pp. 367-376, 2019.

[153] K. Tanaka, H. Takahashi, H. Hyogo, M. Ono, N. Oza, Y. Kitajima, M. Kawanaka, K. Chayama, T. Saibara, K. Anzai, and Y. Eguchi, “Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non-alcoholic fatty liver diseas,” Hepatol Res. 49, pp. 296-303, 2019.

[154] F. Shiromoto, H.H. Aly, H. Kudo, K. Watashi, A. Murayama, N. Watanabe, X. Zheng, T. Kato, K. Chayama, M. Muramatsu, and T. Wakita, “IL-1β/ATF3-mediated induction of Ski2 expression enhances hepatitis B virus x mRNA degradation,” Biochem Biophys Res Commun. 503, pp. 1854-1860, 2018.

[155] L. Shi, K. Fujioka, N. Sakurai-Ozato, W. Fukumoto, K. Satoh, J. Sun, A. Awazu, K. Tanaka, M. Ishida, T. Ishida, Y. Nakano, Y. Kihara, C.N. Hayes, H. Aikata, K. Chayama, T. Ito, K. Awai, and S. Tashiro, “Chromosomal Abnormalities in Human Lymphocytes after Computed Tomography Scan Procedure,” Radiat Res. 190, pp. 424-432, 2018.

[156] T. Maruhashi, J. Soga, N. Fujimura, N. Idei, S. Mikami, Y. Iwamoto, A. Iwamoto, M. Kajikawa, T. Matsumoto, N. Oda, S. Kishimoto, S. Matsui, H. Hashimoto, Y. Aibara, F. Mohamad Yusoff, T. Hidaka, Y. Kihara, K. Chayama, K. Noma, A. Nakashima, C. Goto, H. Tomiyama, B. Takase, T. Kohro, T. Suzuki, T. Ishizu, S. Ueda, T. Yamazaki, T. Furumoto, K. Kario, T. Inoue, S. Koba, K. Watanabe, Y. Takemoto, T. Hano, M. Sata, Y. Ishibashi, K. Node, K. Maemura, Y. Ohya, T. Fu-rukawa, H. Ito, H. Ikeda, A. Yamashina, and Y. Higashi, “Endothelial Dysfunction, Increased Ar-terial Stiffness, and Cardiovascular Risk Prediction in Patients With Coronary Artery Disease: FMD-J (Flow-Mediated Dilation Japan) Study A,” J Am Heart Assoc. 7, pii: e008588, 2018.

[157] Y. H. Yoshiji, Y. Karino, Y. Suzuki, F. Suzuki, M. Uejima, H. Aikata, K. Chayama, H. Iwai, E. Suzuki, and H. Kumada, 2Cross-over study in hyperammonemia patients for efficacy, safety, and acceptability of a new lactulose preparation (SK-1202) compared to approved drug,” Hepatol Res. 48, pp. 1178-1183, 2018.

[158] T. Kawaguchi, K. Tokushige, H. Hyogo, H. Aikata, T. Nakajima, M. Ono, M. Kawanaka, K. Sawada, K. Imajo, K. Honda, H. Takahashi, K. Mori, S. Tanaka, Y. Seko, Y. Nozaki, Y. Kamada, H. Fujii, A. Kawaguchi, T. Takehara, M. Yanase, Y. Sumida, Y. Eguchi, M. Seike, M. Yoneda, Y. Suzuki, T. Saibara, Y. Karino, K. Chayama, E. Hashimoto, J. George, and T. Torimura, “A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD,” Sci Rep. 8, 10434, 2018.

[159] Y. Nakano, H. Ochi, A. Sairaku, Y. Onohara, T. Tokuyama, C. Motoda, H. Matsumura, S. To-momori, M. Amioka, N. Hironobe, Y. Ohkubo, S. Okamura, N. Makita, Y. Yoshida, K. Chayama, and Y. Kihara, “HCN4 Gene Polymorphisms Are Associated With Occurrence of Tachycar-dia-Induced Cardiomyopathy in Patients With Atrial Fibrillation,” Circ Genom Precis Med. 11, e001980, 2018.

[160] M. Furuta, H. Tanaka, Y. Shiraishi, T. Unida, M. Imamura, A. Fujimoto, M. Fujita, A. Sasaki-Oku, K. Maejima, K. Nakano, Y. Kawakami, K. Arihiro, H. Aikata, M. Ueno, S. Hayami, S.I. Ariizumi, M. Yamamoto, K. Gotoh, H. Ohdan, H. Yamaue, S. Miyano, K. Chayama, and H. Nakagawa, “Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers,” Oncotarget. 9, pp. 25075-25088, 2018.

[161] Y. Tsukamoto, S. Ikeda, K. Uwai, R. Taguchi, K. Chayama, T. Sakaguchi, R. Narita, W.L. Yao, F. Takeuchi, Y. Otakaki, K. Watashi, T. Wakita, H. Kato, and T. Fujita, “Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction,” PLoS One, 13, e0197664, 2018.

[162] S. Matsui, M. Kajikawa, T. Maruhashi, H. Hashimoto, Y. Kihara, K. Chayama, C. Goto, Y. Aibara, F.M. Yusoff, S. Kishimoto, A. Nakashima, K. Noma, T. Kawaguchi, T. Matsumoto, and Y. Higash, “New assessment of endothelial function measured by short time flow-mediated vasodilation: Comparison with conventional flow-mediated vasodilation measurement,” Int J Cardiol. 265, pp. 24-29, 2018.

[163] H. Ishiba, Y. Sumida, S. Tanaka, M. Yoneda, H. Hyogo, M. Ono, H. Fujii, Y. Eguchi, Y. Suzuki, H. Takahashi, T. Nakahara, Y. Seko, K. Mori, K. Kanemasa, K. Shimada, S. Imai, K. Imajo, T. Ka-waguchi, A. Nakajima, K. Chayama, T. Saibara, T. Shima, K. Fujimoto, T. Okanoue, and Y. Itoh, “The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study,” J Gastroenterol. 53, pp. 1216-1224, 2018.

[164] S. Matsui, M. Kajikawa, T. Maruhashi, Y. Iwamoto, N. Oda, S. Kishimoto, H. Hashimoto, T. Hid-aka, Y. Kihara, K. Chayama, E. Hida, C. Goto, Y. Aibara, A. Nakashima, F.M. Yusoff, K. Noma, Y. Kuwahara, A. Matsubara, and Y. Higashi, “Endothelial dysfunction, abnormal vascular structure and lower urinary tract symptoms in men and women,” Int J Cardiol. 261, pp. 196-203, 2018.

[165] S. Kishimoto, T. Matsumoto, T. Maruhashi, Y. Iwamoto, M. Kajikawa, N. Oda, S. Matsui, H. Hashimoto, T. Hidaka, Y. Kihara, K. Chayama, C. Goto, Y. Aibara, F.B.M. Yusoff, A. Nakashima, K. Noma, and Y. Higashi, “Reactive hyperemia-peripheral arterial tonometry is useful for assess-ment of not only endothelial function but also stenosis of the digital artery,” Int J Cardiol. 260, pp. 178-183, 2018.

[166] T. Karlas, D. Petroff, M. Sasso, J.G. Fan, Y.Q. Mi, V. de Ledinghen, M. Kumar, M. Lupsor-Platon, K.H. Han, A.C. Cardoso, G. Ferraioli, W.K. Chan, V.W. Wong, R.P. Myers, K. Chayama, M. Frie-drich-Rust, M. Beaugrand, F. Shen, J.B. Hiriart, S.K. Sarin, R. Badea, H.W. Lee, P. Marcellin, C. Filice, S. Mahadeva, G.L. Wong, P. Crotty, K. Masaki, J. Bojunga, P. Bedossa, V. Keim, and J. Wiegand, “Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement,” Aliment Pharmacol Ther. 47, pp. 989-1000, 2018.

[167] K. Kubo, T. Kimura, H. Aikata, S. Takahashi, Y. Takeuchi, I. Takahashi, I. Nishibuchi, Y. Mura-kami, K. Chayama, and Y. Nagata, “Long-term outcome of stereotactic body radiotherapy for pa-tients with small hepatocellular carcinoma,” Hepatol Res. 48, pp. 701-707, 2018.

[168] M. Kawanaka, Y. Tomiyama, H. Hyogo, M. Koda, T. Shima, H. Tobita, A. Hiramatsu, K. Nishino, T. Okamoto, S. Sato, Y. Hara, S. Nishina, H. Kawamoto, K. Chayama, T. Okanoue, and K. Hino, “Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts the development of hepa-tocellular carcinoma in patients with non-alcoholic fatty liver disease,” Hepatol Res. 48, pp. 521-528, 2018.

[169] M. Tsuge, T. Uchida, K. Walsh, Y. Ishida, C. Tateno, U. Kumar, J.S. Glenn, C. Koh, T. Heller, S.L. Uprichard, H. Dahari, and K. Chayama, “Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) Infection,” Viruses. 11, pii, E263, 2019.

[170] C. N. Hayes, P. Zhang, Y. Zhang, and K. Chayama, “Molecular Mechanisms of Hepatocarcino-genesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infec-tion,” Viruses. 10, pii, E531, 2018.

[171] T. Mizumoto, T. Hiyama, D.T. Quach, Y. Sanomura, Y. Urabe, S. Oka, K. Arihiro, S. Tanaka, and K. Chayama, “Magnifying Endoscopy with Narrow Band Imaging in Estimating the Invasion Depth of Superficial Esophageal Squamous Cell Carcinomas,” Digestion. 98, pp. 249-256, 2018.

[172] Y. Ishida, T.L. Chung, M. Imamura, N. Hiraga, S. Sen, H. Yokomichi, C. Tateno, L. Canini, A.S. Perelson, S.L. Uprichard, H. Dahari, and K. Chayama, “Acute hepatitis B virus infection in hu-manized chimeric mice has multiphasic viral kinetics,” Hepatology. 68, pp. 473-484, 2018.

[173] H. Kumada, T. Watanabe, F. Suzuki, K. Ikeda, K. Sato, H. Toyoda, M. Atsukawa, A. Ido, A. Taka-ki, N. Enomoto, K. Kato, K. Alves, M. Burroughs, R. Redman, D. Pugatch, T. J. Pilot-Matias, P. Krishnan, R. K. Oberoi, W. Xie, and K. Chayama, “Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or geno-type 3 infection,” J Gastroenterol. 53, pp. 566-575, 2018.

[174] K. Chayama, F. Suzuki, Y. Karino, Y. Kawakami, K. Sato, T. Atarashi, A. Naganuma, T. Watanabe, Y. Eguchi, H. Yoshiji, M. Seike, Y. Takei, K. Kato, K. Alves, M. Burroughs, R. Redman, D. L. Pu-gatch, T. J. Pilot-Matias, P. Krishnan, R. K. Oberoi, W. Xie, and H. Kumada, “Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis,” J Gastroenterol. 53, pp. 557-565, 2018.

[175] A. Naganuma, K. Chayama, K. Notsumata, E. Gane, G.R. Foster, D. Wyles, P. Kwo, E. Crown, A. Bhagat, F.J. Mensa, T. Otani, L. Larsen, M. Burroughs, and H. Kumada, “Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepa-titis C virus genotype 1 or 2 infection,” J Gastroenterol. 54, pp. 752-761, 2019.

[176] N. Hamdane, F. Juhling, E. Crouchet, H. El Saghire, C. Thumann, M.A. Oudot, S. Bandiera, A. Saviano, C. Ponsolles, A.A. Roca Suarez, S. Li, N. Fujiwara, A. Ono, I. Davidson, N. Bardeesy, C. Schmidl, C. Bock, C. Schuster, J. Lupberger, F. Habersetzer, M. Doffoel, T. Piardi, D. Sommacale, M. Imamura, T. Uchida, H. Ohdan, H. Aikata, K. Chayama, T. Boldanova, P. Pessaux, B.C. Fuchs, Y. Hoshida, M.B. Zeisel, F.H.T. Duong, and T.F. Baumert, “HCV-induced Epigenetic Changes As-sociated With Liver Cancer Risk Persist After Sustained Virologic Response,” Gastroenterology. pii: S0016-5085(19)32506-5, 2019.

[177] T. Takehara, N. Sakamoto, S. Nishiguchi, F. Ikeda, T. Tatsumi, Y. Ueno, H. Yatsuhashi, Y. Tak-ikawa, T. Kanda, M. Sakamoto, A. Tamori, E. Mita, K. Chayama, G. Zhang, S. De-Oertel, H. Dvory-Sobol, T. Matsuda, L.M. Stamm, D.M. Brainard, Y. Tanaka, and M. Kurosaki, “Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial,” J Gastroenterol. 54, pp. 87-95, 2019.

[178] F. Bazerbachi, S. Haffar, Z. Wang, J. Cabezas, M.T. Arias-Loste, J. Crespo, S. Darwish-Murad, M.A. Ikram, J.K. Olynyk, E. Gan, S. Petta, A. Berzuini, D. Prati, V. de Ledinghen, V.W. Wong, P. Del Poggio, N.C. Chavez-Tapia, Y.P. Chen, P.N. Cheng, M.F. Yuen, K. Das, A. Chowdhury, L. Ca-balleria, N. Fabrellas, P. Gines, M. Kumar, S.K. Sarin, F. Conti, P. Andreone, R. Sirli, H. Cor-tez-Pinto, S. Carvalhana, T. Sugihara, S.U. Kim, P. Parikh, K. Chayama, C. Corpechot, K.M. Kim, G. Papatheodoridis, A. Alsebaey, P.S. Kamath, M.H. Murad, and K.D. Watt, “Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals,” Clin Gastroenterol Hepatol. 17, pp. 54-64, 2019.

[179] N. Izumi, T. Takehara, K. Chayama, H. Yatsuhashi, K. Takaguchi, T. Ide, M. Kurosaki, Y. Ueno, H. Toyoda, S. Kakizaki, Y. Tanaka, Y. Kawakami, H. Enomoto, F. Ikeda, D. Jiang, S. De-Oertel, B.L. McNabb, G. Camus, L.M. Stamm, D.M. Brainard, J.G. McHutchison, S. Mochida, and M. Mizo-kami, “Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals,” Hepatol Int. 12, pp. 356-367, 2018.

[180] T. Lund Laursen, C. Brockner Siggard, K. Kazankov, T. Damgaard Sandahl, H.J. Moller, A. Ong, M.W. Douglas, J. George, B. Tarp, L. Hagelskjaer Kristensen, A. Lund Laursen, A. Hiramatsu, T. Nakahara, K. Chayama, and H. Gronbaek, “Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology,” Scand J Gastroenterol. 53, pp. 986-993, 2018.

[181] A. Boot, M. N. Huang, A. W. T. Ng, S. C. Ho, J. Q. Lim, Y. Kawakami, K. Chayama, B. T. Teh, H. Nakagawa, and S. G. Rozen, “In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors,” Genome Res. 28, pp. 654-665, 2018.

[182] N. Akuta, J. Toyota, Y. Karino, F. Ikeda, A. Ido, K. Tanaka, K. Takaguchi, A. Naganuma, E. To-mita, K. Chayama, S. Fujiyama, Y. Inada, H. Yoshiji, H. Watanabe, H. Ishikawa, F. McPhee, S. Noviello, and H. Kumada, “Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection,” J Gastroenterol. 53, pp. 1089-1097, 2018.

[183] A. Rolt, D. Le, Z. Hu, A.Q. Wang, P. Shah, M. Singleton, E. Hughes, A.E. Dulcey, S. He, M. Imamura, T. Uchida, K. Chayama, X. Xu, J.J. Marugan, and T.J. Liang, “Preclinical Pharmacolog-ical Development of Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection,” J Infect Dis. 217, pp. 1761-1769, 2018.

[184] C.P. Wardell, M. Fujita, T. Yamada, M. Simbolo, M. Fassan, R. Karlic, P. Polak, J. Kim, Y. Hat-anaka, K. Maejima, R.T. Lawlor, Y. Nakanishi, T. Mitsuhashi, A. Fujimoto, M. Furuta, A. Ruzzenente, S. Conci, A. Oosawa, A. Sasaki-Oku, K. Nakano, H. Tanaka, Y. Yamamoto, K. Mich-iaki, Y. Kawakami, H. Aikata, M. Ueno, S. Hayami, K. Gotoh, S.I. Ariizumi, M. Yamamoto, H. Yamaue, K. Chayama, S. Miyano, G. Getz, A. Scarpa, S. Hirano, T. Nakamura, and H. Nakagawa, “Genomic characterization of biliary tract cancers identifies driver genes and predisposing muta-tions,” J Hepatol. 68, pp. 959-969, 2018.

[185] K. R. Reddy, S. Pol, P. J. Thuluvath, H. Kumada, J. Toyota, K. Chayama, J. Levin, E. J. Lawitz, A. Gadano, W. Ghesquiere, G. Gerken, M. R. Brunetto, C. Y. Peng, M. Silva, S. I.Strasser, J. Heo, F. McPhee, Z. Liu, R. Yang, M. Linaberry, and S. Noviello, “Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens,” Liver Int. 38, pp. 821-833, 2018.

[186] N. Van Renne, A. A. Roca Suarez, F. H. T. Duong, C. Gondeau, D. Calabrese, N. Fontaine, A. Ab-absa, S. Bandiera, T. Croonenborghs, N. Pochet, V. De Blasi, P. Pessaux, T. Piardi, D. Sommacale, A. Ono, K. Chayama, M. Fujita, H. Nakagawa, Y. Hoshida, M. B. Zeisel, M. H. Heim, T. F. Baumert, and J. Lupberger, “miR-135a-5p-mediated downregulation of protein tyrosine phospha-tase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis,” Gut. 67, pp. 953-962, 2018.

[187] Y. Nagaoki, H. Aikata, K. Daijyo, Y. Teraoka, F. Honda, Y. Nakamura, M. Hatooka, K. Morio, H. Fujino, T. Nakahara, T. Kawaoka, D. Miki, M. Tsuge, A. Hiramatsu, M. Imamura, Y. Kawakami, H. Ochi, and K. Chayama, “Risk factors for exacerbations of gastroesophageal varices and portosys-temic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus-related cir-rhosis,” Hepatol Res. 48(4), pp. 264-274, 2018.

[188] K. Kodama, T. Kawaoka, H. Aikata, S. Uchikawa, Y. Nishida, Y. Inagaki, M. Hatooka, K. Morio, T. Nakahara, E. Murakami, M. Tsuge, A. Hiramatsu, M. Imamura, Y. Kawakami, K. Masaki, Y. Honda, N. Mori, S. Takaki, K. Tsuji, H. Kohno, T. Moriya, M. Nonaka, H. Hyogo, Y. Aisaka, T. Kimura, Y. Nagata, and K. Chayama, “Comparison of outcome of hepatic arterial infusion chem-otherapy combined with radiotherapy and sorafenib for advanced hepatocellular carcinoma pa-tients with major portal vein tumor thrombosis,” Oncology. 94(4), pp. 215-22, 2018.

[189] Y. Tatsukawa, M. Tsuge, Y. Kawakami, Y. Hiyama, E. Murakami, M. Kurihara, M. Nomura, K. Tsushima, T. Uchida, T. Nakahara, D. Miki, T. Kawaoka, H. Abe-Chayama, M. Imamura, H. Ai-kata, H. Ochi, C.N. Hayes, H. Kawakami, and K. Chayama, “Reduction of hepatitis B surface an-tigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study,” Antivir Ther. 23(8), pp. 639-46, 2018.

[190] Y. Teraoka, T. Uchida, M. Imamura, N. Hiraga, M. Osawa, H. Kan, Y. Saito, M. Tsuge, H. Abe-Chayama, C.N. Hayes, G.N. Makokha, H. Aikata, D. Miki, H. Ochi, Y. Ishida, C. Tateno, and K. Chayama, “Limitations of daclatasvir/asunaprevir plus beclabuvir treatment in cases of NS5A inhibitor treatment failure,” J Gen Virol. 99(8), pp.1058-65, 2018.

[191] M. Osawa, M. Imamura, Y. Teraoka, T. Uchida, K. Morio, H. Fujino, T. Nakahara, A. Ono, E. Murakami, T. Kawaoka, D. Miki, M. Tsuge, A. Hiramatsu, H. Aikata, C.N. Hayes, and K. Chayama, “Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures,” J Gastroenterol. 54(3), pp. 291-6, 2019.

[192] K. Kodama, T. Kawaoka, M. Namba, S. Uchikawa, K. Ohya, K. Morio, T. Nakahara, E. Muraka-mi, M. Yamauchi, A. Hiramatsu, M. Imamura, K. Chayama, and H. Aikata, “Correlation between early tumor marker response and imaging response in patients with advanced hepatocellular car-cinoma treated with lenvatinib,” Oncology. 97(2), pp.75-81, 2019.

[193] C. N. Hayes, M. Imamura, and K. Chayama, “Manegement of HCV patients in cases of di-rect-acting antiviral failure,” Expert Rev Gastroenterol Hepatol. 13(9), pp.839-48, 2019.

[194] K. Ohya, T. Kawaoka, M. Namba, S. Uchikawa, K. Kodama, K. Morio, T. Nakahara, E. Muraka-mi, A. Hiramatsu, M. Tsuge, M. Yamauchi, M. Imamura, K. Chayama, and H. Aikata, “Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy,” Sci Rep. 9(1), 12101, 2019.

[195] M. Hide, A. Igarashi, A. Yagami, Y. Chinuki, N. Inomata, A. Fukunaga, G. Kaiser, J. Wang, S. Matsushima, S. Greenberg, and S. Khalil, “Efficacy and safety of omalizumab for the treatment of refractory chronic spontaneous urticaria in Japanese patients: Subgroup analysis of the phase 3 POLARIS study,” Allergol Int. 67(2), pp. 243-52, 2018.

[196] M. Hide, T. Suzuki, A. Tanaka, and H. Aoki, “Efficacy and safety of rupatadine in Japanese adult and adolescent patients with chronic spontaneous urticaria: A double-blind, randomized, multi-center, placebo-controlled clinical trial,” Allergol Int. 68(1), pp. 59-67, 2019.

[197] A. Itakura, Y. Tani, N. Kaneko, and M. Hide, “Impact of chronic urticaria on quality of life and work in Japan: Results of a real-world study,” J Dermatol. 45(8), pp. 963-970, 2018.

[198] T. Kan, S. Takahagi, H. Shindo, A. Tanaka, M. Kawai, and M. Hide, “A unique clinical phenotype of a patient bearing a newly identified deletion mutation in the PSENEN gene along with the pathogenic serum desmoglein-1 antibody,” Clin Exp Dermatol. 43(3), pp. 329-332, 2018.

[199] T. Kohsaka, T. Hiragun, K. Ishii, M. Hiragun, A. Kamegashira, and M. Hide, “Different hypersen-sitivities against homologous proteins of MGL_1304 in patients with atopic dermatitis,” Allergol Int. 67(1), pp. 103-108, 2018.

[200] Y. Matsuo, Y. Yanase, R. Irifuku, K. Ishii, T. Kawaguchi, S. Takahagi, I. Hide, and M. Hide, “The role of adenosine for IgE receptor-dependent degranulation of human peripheral basophils and skin mast cells,” Allergol Int. 67(4), pp. 524-526, 2018.

[201] Y. Matsuo, Y. Yanase, R. Irifuku, S. Takahagi, S. Mihara, K. Ishii, T. Kawaguchi, A. Tanaka, K. Iwamoto, H. Watanuki, K. Furuta, S. Tanaka, A. Inoue, J. Aoki, and M. Hide, “Neuromedin U di-rectly induces degranulation of skin mast cells, presumably via MRGPRX2,” Allergy. 73(11), pp. 2256-2260, 2018.

[202] M. Moriwaki, K. Iwamoto, K. Ishii, S. Takahagi, and M. Hide, “Case of anaphylaxis to lansopra-zole confirmed by histamine release test and oral provocation test,” J Dermatol. 46(4), e124-e125, 2019.

[203] M. Moriwaki, K. Iwamoto, Y. Niitsu, A. Matsushima, Y. Yanase, J. Hisatsune, M. Sugai, and M. Hide, “Staphylococcus aureus from atopic dermatitis skin accumulates in the lysosomes of keratinocytes with induction of IL-1alpha secretion via TLR9,” Allergy. 74(3), pp. 560-571, 2019.

[204] S. Oka, S. Tsuboi, C. Morita, N. Umeda, M. Kawai, H. Itakura, and M. Hide, “Two cases of con-junctival squamous cell carcinoma in the anophthalmic socket after treatment of retinoblastoma,” J Dermatol. 45(12), e346-e347, 2018.

[205] M. Okamoto, S. Takahagi, A. Tanaka, A. Ogawa, H. Nobuki, and M. Hide, “A case of Kaposi var-icelliform eruption progressing to herpes simplex virus hepatitis in an immunocompetent patient,” Clin Exp Dermatol. 43(5), pp. 636-8, 2018.

[206] R. Saito, K. Iwamoto, Y. Tanaka, M. Kawai, and M. Hide, “Rapid exacerbation of malignant mel-anoma during short-term discontinuation of vemurafenib,” Australas J Dermatol. 59(4), e274-e6, 2018.

[207] R. Saito, M. Kawai, K. Hirakawa, M. Tanaka, S. Takahagi, and M. Hide, “Case of malignant mel-anoma responding to dacarbazine following nivolumab,” Dermatol Ther. 32(2), e12791, 2019.

[208] S. Takahagi, A. Tanaka, and M. Hide, “Sweat allergy,” Allergol Int. 67(4), pp. 435-441, 2018.

[209] Y. Yanase, Y. Matsuo, T. Kawaguchi, K. Ishii, A. Tanaka, K. Iwamoto, S. Takahagi, and M. Hide, “Activation of Human Peripheral Basophils in Response to High IgE Antibody Concentrations without Antigens,” Int J Mol Sci. 20(1), 2018.

[210] Y. Yanase, S. Morioke, K. Iwamoto, S. Takahagi, K. Uchida, T. Kawaguchi, K. Ishii, I. Hide, and M. Hide, “Histamine and Toll-like receptor ligands synergistically induce endothelial cell gap for-mation by the extrinsic coagulating pathway,” J Allergy Clin Immunol. 141(3), 1115-8.e7, 2018.

[211] Y. Yanase, S. Takahagi, and M. Hide, “Chronic spontaneous urticaria and the extrinsic coagulation system,” Allergol Int. 67(2), pp. 191-194, 2018.

[212] Y. Yanase, S. Takahagi, and M. Hide, “Role of TF-triggered activation of the coagulation cascade in the pathogenesis of chronic spontaneous urticarial,” Curr Treat Options Allergy. 5(4), pp. 383-391, 2018.

[213] Y. Shibata, Y. Sagara, T. Yokooji, T. Taogoshi, M. Tanaka, M. Hide, and H.Matsuo, “Evaluation of Risk of Injury by Extravasation of Hyperosmolar and Vasopressor Agents in a Rat Model,” Biol Pharm Bull. 41(6), pp. 951-956, 2018.

[214] M. Hide, A. Igarashi, A. Yagami, Y. Chinuki, N. Inomata, A. Fukunaga, G. Kaiser, J. Wang, S. Matsushima, S. Greenberg, and S. Khalil, “Efficacy and safety of omalizumab for the treatment of refractory chronic spontaneous urticaria in Japanese patients: Subgroup analysis of the phase 3 POLARIS study,” Allergol Int. 67(2), pp. 243-252, 2018.

[215] S. Kasami, J. Sowa-Osako, K. Fukai, S. Tokimasa, S.I. Kaga, R. Saito, A. Tanaka,M. Hide, and D. Tsuruta, “Presymptomatic genetic diagnosis of two siblings with hereditary angioedema, presenting with unusual normal levels of serum C4,” J Dermatol. 45(2), e31-2, 2018.

[216] M. Maurer, M. Magerl, I. Ansotegui, E. Aygoren-Pursun, S. Betschel, K. Bork, T. Bowen, H. Balle Boysen, H. Farkas, A.S. Grumach, M. Hide, C. Katelaris, R. Lockey, H. Longhurst, W.R. Lumry, I. Martinez-Saguer, D. Moldovan, A. Nast, R. Pawankar, P. Potter, M. Riedl, B. Ritchie, L. Rosen-wasser, M. Sanchez-Borges, Y. Zhi, B. Zuraw, and T. Craig, “The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update,” Allergy. 73(8), pp. 1575-1596, 2018.

[217] T. Zuberbier, W. Aberer, R. Asero, A.H. Abdul Latiff, D. Baker, B. Ballmer-Weber, J.A. Bernstein, C. Bindslev-Jensen, Z. Brzoza, R. Buense Bedrikow, G.W. Canonica, M.K. Church, T. Craig, I.V. Danilycheva, C. Dressler, L.F. Ensina, A. Gimenez-Arnau, K. Godse, M. Goncalo, C. Grattan, J. Hebert, M. Hide, A. Kaplan, A. Kapp, C.H. Katelaris, E. Kocaturk, K. Kulthanan, D. Larenas-Linnemann, T.A. Leslie, M. Magerl, P. Mathelier-Fusade, R.Y. Meshkova, M. Metz, A. Nast, E. Nettis, H. Oude-Elberink, S. Rosumeck, S.S. Saini, M. Sanchez-Borges, P. Schmid-Grendelmeier, P. Staubach, G. Sussman, E. Toubi, G.A. Vena, C. Vestergaard, B. Wedi, R.N. Werner, Z. Zhao and M. Maurer, “Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA2LEN, IAACI, IADVL, JDA, NVvA, MSAI, OGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classifi-cation, diagnosis and management of urticarial,” Allergy. 73(7), pp. 1393-1414, 2018.

[218] H. Nikawa, “To add the statistical data,” J Investig Clin Dent, 9(2), e12301, 2018.

[219] O. Yuki, C. Furutani, Y. Mizota, A. Wakita, S. Mimura, T. Kihara, M. Ohara, Y. Okada, M. Okada, and H.Nikawa, “Effect of bovine milk fermented with Lactobacillus rhamnosus L8020 on perio-dontal disease in individuals with intellectual disability: a randomized clinical trial,” J Appl Oral Sci, pp. 1-9, 2019.

[220] 三村純代, 赤木里紗, 田地 豪, 二川浩樹, “L8020乳酸菌の口腔内残存時間に関する研究,” 日衛学誌13(1), pp. 47-53, 2018.

[221] 笹原 妃佐子, 西村 瑠美, 深田 恵里, 二川 浩樹, “大学生の健康診断時に喫煙に対する虚偽回答に関する研究,” 総合保健科学 広島大学保健管理センター研究論文集, 34,1-12,2018.

[222] 笹原 妃佐子, 前原 朝子, 二川 浩樹, “大学生における喫煙に関数する要因について -在学中1年から4年生までの縦断的研究-,” Campus Health, 55,113-119, 2018.

[223] 笹原 妃佐子, 深田 恵里, 西村 瑠美, 二川 浩樹, “国勢調査員への歯科学生登用について -平成27年度 第20回国勢調査員を経験して-,”広大歯誌, 50(1), 1-8, 2018.

[224] K. Nakajima, R. Kunimatsu, K. Ando, T. Ando, Y. Hayashi, T. Kihara, T. Hiraki, Y. Tsuka, T. Abe, M. Kaku, H. Nikawa, T. Takata, K. Tanne, and K. Tanimoto, “Comparison of the bone regenera-tion ability between stem cells from human exfoliated deciduous teeth, human dental pulp stem cells and human bone marrow mesenchymal stem cells,” Biochem Biophys Res Commun, 497(3), pp. 876-882, 2018.

[225] A. N. Abdullah, S. Miyauchi, A. Onishi, K. Tanimoto, and K. Kato, “Differentiation of mouse iPS cells into dental epithelial-like cells in the absence of added serum,” In Vitro Cell. Dev. Biol. Ani-mal, 55(2), pp. 130-137, 2019.

[226] H. Tsuka, K. Morita, K. Kato, H. Abekura, I. Hirata, K. Kato, and K. Tsuga, “Effect of laser groove treatment on shear bond strength of adhesive resin cement to polyetheretherketone (PEEK),” J Prosthodontic Res. 63, pp. 52-57, 2019.

[227] Y. Aida, H. Kurihara, and K. Kato, “Wnt3a promotes differentiation of bone marrow-derived mesenchymal stem cells into cementoblast-like cells,” In Vitro Cell. Dev. Biol. Animal, 54(6), pp. 468-476, 2018.

[228] K. Kato, K. Morita, I. Hirata, K. Doi, T. Kubo, K. Kato, and K. Tsuga, “Enhancement of calcifica-tion by osteoblasts cultured on hydroxyapatite surfaces with adsorbed inorganic polyphosphate,” In Vitro Cell. Dev. Biol. Animal, 54(6), pp. 449-457, 2018.

[229] S. Shimoe, I. Hirata, M. Otaku, K. Kato, and T. Satoda. “Formation of chemical bonds at zirconia surfaces with acidic functional monomers,” J. Oral Sci., 60(2), pp. 187-193, 2018.

Page
Top